Organ Transplantation Market Trends, Size, Share, Segments, Emerging Technologies and Market Growth by Forecast to 2026
Organ transplant is a surgical process in which an
organ is removed from one body and grafted into another body. Organ transplant
is the only treatment option in case of end-stage organ failure. The global organ
transplantation market is set to capture a CAGR of 9.8% over the forecast
period 2017-2023, reveals a study by Market Research Future (MRFR).
The number of organ transplants worldwide has
increased slowly over the recent years. Rising prevalence of chronic diseases
and organ failures are the primary drivers of the market. Increase in diseases
such as diabetes and high blood pressure, which results in renal diseases,
unhealthy diet and over-consumption of alcohol has provided an impetus to the
growth of the market. Additionally, technological advancements which have made
surgeries minimally-invasive, safer and reduced cost of organ transplants has
spurred the market for organ transplant. The rise in the geriatric population,
rise in organ donation due to growing organ donation awareness, the high
success rate of transplantation, increasing aid from private and government
authorities, improving healthcare infrastructure, and wide adoption of organ
transplant propel the market for organ transplantation. Extensive R&D in
the field of organ transplantation and rise in transplant tourism has further
fueled the growth of the market.
On the flip side, scarcity of donors, ethical
concerns in organ transplants, lack of trained healthcare experts, the high
cost of treatment, and increasing incidences of organ failure is likely to
hamper the growth of the market. Histocompatibility is a principal barrier for
organ transplantation where tissue compatibility between the donor and
recipient determines the possibility of organ transplant. Shortage of organs is
a significant restraint to the market. Religious and social beliefs and lack of
awareness regarding organ donation has impeded the market growth significantly.
Furthermore, the emergence of stem cells therapies as an alternative to organ
transplantation might restrict the growth of the market.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/915
Segmentation
The global organ transplantation market has been
segmented based on type of organ, products, type of transplant, treatment, and
end-users. By type of organ, the market has been segmented into heart, kidney,
liver, lungs and other. By products, the market has been segmented into organ
preservation solution, transplant diagnostics, tissue products and others. By
type of transplant, the market has been segmented into autograft, allograft and
allotransplantation, xenograft and xenotransplantation and others. By
treatment, the market has been segmented into analgesic, immunosuppressant and
others. The immunosuppressant sub-segment has been further divided into
calcineurin inhibitor, antiproliferative agents, steroids and others.
Calcineurin Inhibitors has been further segmented into tacrolimus and
cyclosporine. mTOR inhibitors has been further segmented into sirolimus and everolimus.
By end-users, the market has been segmented into hospitals, transplant centers,
and others.
Regional
Analysis
The key markets of the global organ transplantation
market include America, Europe, Asia Pacific and Middle East & Africa.
America is dominating the organ transplantation market owing to the prevalence
of chronic diseases, rise in geriatric population, wide adoption of organ
transplant and robust healthcare infrastructure in the region. Europe is the
second largest market for organ transplantation, followed by Asia-Pacific.
Increasing investment in R&D, the emergence of many new research
organizations and developed healthcare facilities has propelled the market in
Europe. Asia-Pacific is emerging as a key principal market for organ transplantation
due to rapid development in the healthcare sector, and presence of large
disease population pool in the region. Poor economic conditions has restricted
the market growth in Middle East & Africa.
Competitive
Landscape
Shortage characterizes the global organ
transplantation market; the market is monopolistic and competitive; entry into
the market is strictly prohibited by law. The eminent players operating in the
market include Novartis International AG (Switzerland), Transonic (US),
Astellas Pharma, Inc (Japan), OrganOX Limited (UK), Transplant Biomedical (UK),
Accord Healthcare GmbH (Spain), Pfizer, Inc. (US), GlaxoSmithKline Plc. (UK),
Terumo Medical Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland),
Preservation Solutions, Inc. (US), Bio Med Pvt. Ltd. (US), TransMedic, Inc.
(US), Sanofi (France), and Veloxis Pharmaceuticals A/S (Denmark).
Industry
Trends/Updates
- Dr. Robert Redfield, a transplant surgeon at UW hospital, has
teamed up with another expert for using pigs as organ donors for organ
transplantation. They plan to create pigs who can be customized to needs
of kidney, pancreases or other organ transplant.
- In May 2018, China was appreciated at the 71st World Health
Assembly (WHA) for its model and experience in organ transplantation.
China's model of organ donation and transplantation reflects strong
government support and a robust healthcare sector.
- The National Institutes of Health announced the launch of a new
clinical trial which might pave the way for HIV-to-HIV kidney transplant.
The trail is the zenith of almost a decade of work and will include 160
kidney transplants to HIV-positive patients.
Access Report
Details @ https://www.marketresearchfuture.com/reports/organ-transplantation-market-915
Related Report: Dysmenorrhea
Treatment Market Research Report- Global Forecast to 2027
Syringe
and Needle Market Research Report - Global Forecast to 2027
Global
Medical Robotics Market Research Report- Forecast To 2027
Global
Neuromodulation Devices Market Research Report- Forecast To 2027
Global
Erythropoietin Drug Market Research Report- Forecast To 2027
About US:
Market Research Future (MRFR)
enable customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting
Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New
York,
New York 10013
Comments
Post a Comment